항균제 내성 감시 시장 : 세계 규모, 점유율, 동향 분석, 기회, 예측(2019-2029년)

Global Antimicrobial Resistance Surveillance Market Size Expands at Steady CAGR of 5.6% During 2023-2029 to Touch USD 7.92 Billion by 2029

Global Antimicrobial Resistance Surveillance Market is flourishing because of increasing adoption of innovative diagnostic technologies to diagnose and treat growing incidences of hospital-acquired infections.

BlueWeave Consulting, a leading strategic consulting and market research firm, in its recent study, estimated the Global Antimicrobial Resistance Surveillance Market size at USD 5.71 billion in 2022. During the forecast period between 2023 and 2029, BlueWeave expects Global Antimicrobial Resistance Surveillance Market size to grow at a CAGR of 5.6% reaching a value of USD 7.92 billion by 2029. Major growth drivers for the Global Antimicrobial Resistance Surveillance Market include an increasing incidence of infections attributed to drug-resistant pathogens, advancements in diagnostic technologies, a rising concern over antimicrobial resistance, governmental efforts to address antimicrobial resistance, and the emergence of multi-drug resistance linked to drug abuse. Notably, advanced imaging technologies now deliver clinical information swiftly, contrasting with traditional culture-based methods taking up to 48 hours for susceptibility data. The emergence of new techniques detecting drug resistance without lengthy culture processes shortens the diagnostic timeframe by at least a day. Faster and more advanced diagnostic tests are expected to drive growth in the antimicrobial resistance diagnostics market. Also, nosocomial infections, acquired during hospitalization, encompass diverse illnesses. Hospital-acquired infections, such as central line-associated bloodstream infections and urinary tract infections from catheters, are widespread. The prevalence of these infections is poised to boost the antimicrobial resistance diagnostics market, reflecting the growing use of invasive techniques and equipment in modern healthcare. However, high costs associated with antimicrobial resistance surveillance system and kits and technical challenges in the end-user are anticipated to restrain the overall market growth during the forecast period.

Opportunity - Initiatives to Increase Awareness about Antimicrobial Resistance and Control

Antimicrobial resistance (AMR) is a pervasive global threat to human health, prompting a unified response through the Global Action Plan for AMR (GAP-AMR) in 2015. The initiative aims to ensure sustained success in treating infectious diseases by providing effective, safe, and quality-assured medicines responsibly. Surveillance, led by the Global Antimicrobial Resistance and Use Surveillance System (GLASS), is pivotal for policy formulation and infection control. GLASS standardizes data collection, analysis, and interpretation, promoting a shift towards comprehensive surveillance encompassing epidemiological, clinical, and population-level data. It actively engages in capacity building and partners with WHO and regional networks to bridge knowledge gaps and inform strategies, contributing significantly to global AMR awareness initiatives.

Impact of COVID-19 on Global Antimicrobial Resistance Surveillance Market

COVID-19 pandemic had a positive impact on Global Antimicrobial Resistance Surveillance Market. Several factors contributed to this exacerbation, including heightened antibiotic use for COVID-19 patients, disruptions in infection control measures within overwhelmed healthcare systems, and the redirection of resources away from monitoring and addressing antimicrobial resistance (AMR) threats. The pandemic necessitated the adoption of virtual visits and rapid diagnostic testing to minimize hospital visits. Even post-pandemic, home-based healthcare is expected to remain essential, particularly for individuals with pre-existing conditions, thereby fueling the demand for diagnostic assays.

Global Antimicrobial Resistance Surveillance Market - By End User

On the basis of end user, the Global Antimicrobial Resistance Surveillance Market is split into Hospitals & Clinics and Research & Academic Institutes segments. The hospitals & clinics segment holds a higher share in the Global Antimicrobial Resistance Surveillance Market by end user, primarily due to the elevated patient density observed in hospitals and clinics, the rising incidence of nosocomial infections within hospital settings, and the imperative to uphold stringent infection control protocols.

Global Antimicrobial Resistance Surveillance Market - By Region

The in-depth research report on the Global Antimicrobial Resistance Surveillance Market covers various country-specific markets across five major regions: North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. North America region holds the highest share in the Global Antimicrobial Resistance Surveillance Market. The region's dominance is attributed to its well-established healthcare systems and advanced laboratory facilities in the United States and Canada. These major countries exhibit substantial investments in antimicrobial resistance (AMR) surveillance, with a specific focus on clinical diagnostics and data collection. The region's robust healthcare infrastructure and high standards of patient care contribute to the significant share held by clinical diagnostics in North America. Notably, the Centers for Disease Control and Prevention (CDC) in the United States spearhead AMR surveillance efforts. Meanwhile, the Asia Pacific region is expected to witness the fastest growth rate during the forecast period. China, in particular, has made noteworthy investments in AMR surveillance, establishing a national data collection network. Collaboration with international organizations, such as the World Health Organization (WHO), further enhances the region's efforts. The Asia Pacific region, encompassing diverse healthcare systems and population sizes, including China and India, encounters distinct challenges, prompting an upsurge in public health surveillance initiatives facilitated by regional and global health organizations.

Competitive Landscape

Major players operating in the Global Antimicrobial Resistance Surveillance Market include Becton, Dickinson and Company, Biomerieux, Thermo Fisher Scientific, Danaher, Luminex Corporation, Bruker, Bio-Rad, Qiagen, Abbott Laboratories, Roche Diagnostics, OpGen, Inc., Wolters Kluwer N.V., Lumed, BioSpace, and Cepheid. To further enhance their market share, these companies employ various strategies, including mergers and acquisitions, partnerships, joint ventures, license agreements, and new product launches.

The in-depth analysis of the report provides information about growth potential, upcoming trends, and statistics of Global Antimicrobial Resistance Surveillance Market. It also highlights the factors driving forecasts of total market size. The report promises to provide recent technology trends in Global Antimicrobial Resistance Surveillance Market and industry insights to help decision-makers make sound strategic decisions. Furthermore, the report also analyzes the growth drivers, challenges, and competitive dynamics of the market.

Table of Contents

1. Research Framework

• 1.1. Research Objective
• 1.2. Product Overview
• 1.3. Market Segmentation

2. Executive Summary

3. Global Antimicrobial Resistance Surveillance Market Insights

• 3.1. Industry Value Chain Analysis
• 3.2. DROC Analysis
  • 3.2.1. Growth Drivers
    • 3.2.1.1. Increasing innovation in diagnostic technologies
    • 3.2.1.2. Increasing incidences of hospital-acquired infections
  • 3.2.2. Restraints
    • 3.2.2.1. High costs associated with antimicrobial resistance surveillance system and kits
    • 3.2.2.2. Technical challenges in the End User
  • 3.2.3. Opportunities
    • 3.2.3.1. Awareness initiatives for antimicrobial resistance and control
    • 3.2.3.2. Growth opportunities in emerging economies
  • 3.2.4. Challenges
    • 3.2.4.1. Complex regulatory framework
• 3.3. Technological Advancements/Recent Developments
• 3.4. Regulatory Framework
• 3.5. Porter's Five Forces Analysis
  • 3.5.1. Bargaining Power of Suppliers
  • 3.5.2. Bargaining Power of Buyers
  • 3.5.3. Threat of New Entrants
  • 3.5.4. Threat of Substitutes
  • 3.5.5. Intensity of Rivalry

4. Global Antimicrobial Resistance Surveillance Market Overview

• 4.1. Market Size & Forecast, 2019-2029
  • 4.1.1. By Value (USD Million)
• 4.2. Market Share and Forecast
  • 4.2.1. By Solution
    • 4.2.1.1. Diagnostic kits
    • 4.2.1.2. Diagnostic systems
    • 4.2.1.3. Surveillance software
    • 4.2.1.4. Services
  • 4.2.2. By Application
    • 4.2.2.1. Clinical Diagnostics
    • 4.2.2.2. Public Health Surveillance
    • 4.2.2.3. Other
  • 4.2.3. By End User
    • 4.2.3.1. Hospitals & Clinics
    • 4.2.3.2. Research & Academic Institutes
    • 4.2.3.3. Others
  • 4.2.4. By Region
    • 4.2.4.1. North America
    • 4.2.4.2. Europe
    • 4.2.4.3. Asia Pacific (APAC)
    • 4.2.4.4. Latin America (LATAM)
    • 4.2.4.5. Middle East and Africa (MEA)

5. North America Antimicrobial Resistance Surveillance Market

• 5.1. Market Size & Forecast, 2019-2029
  • 5.1.1. By Value (USD Million)
• 5.2. Market Share & Forecast
  • 5.2.1. By Solution
  • 5.2.2. By Application
  • 5.2.3. By End User
  • 5.2.4. By Country
    • 5.2.4.1. United States
    • 5.2.4.1.1. By Solution
    • 5.2.4.1.2. By Application
    • 5.2.4.1.3. By End User
    • 5.2.4.2. Canada
    • 5.2.4.2.1. By Solution
    • 5.2.4.2.2. By Application
    • 5.2.4.2.3. By End User

6. Europe Antimicrobial Resistance Surveillance Market

• 6.1. Market Size & Forecast, 2019-2029
  • 6.1.1. By Value (USD Million)
• 6.2. Market Share & Forecast
  • 6.2.1. By Solution
  • 6.2.2. By Application
  • 6.2.3. By End User
  • 6.2.4. By Country
    • 6.2.4.1. Germany
    • 6.2.4.1.1. By Solution
    • 6.2.4.1.2. By Application
    • 6.2.4.1.3. By End User
    • 6.2.4.2. United Kingdom
    • 6.2.4.2.1. By Solution
    • 6.2.4.2.2. By Application
    • 6.2.4.2.3. By End User
    • 6.2.4.3. Italy
    • 6.2.4.3.1. By Solution
    • 6.2.4.3.2. By Application
    • 6.2.4.3.3. By End User
    • 6.2.4.4. France
    • 6.2.4.4.1. By Solution
    • 6.2.4.4.2. By Application
    • 6.2.4.4.3. By End User
    • 6.2.4.5. Spain
    • 6.2.4.5.1. By Solution
    • 6.2.4.5.2. By Application
    • 6.2.4.5.3. By End User
    • 6.2.4.6. Belgium
    • 6.2.4.6.1. By Solution
    • 6.2.4.6.2. By Application
    • 6.2.4.6.3. By End User
    • 6.2.4.7. Russia
    • 6.2.4.7.1. By Solution
    • 6.2.4.7.2. By Application
    • 6.2.4.7.3. By End User
    • 6.2.4.8. The Netherlands
    • 6.2.4.8.1. By Solution
    • 6.2.4.8.2. By Application
    • 6.2.4.8.3. By End User
    • 6.2.4.9. Rest of Europe
    • 6.2.4.9.1. By Solution
    • 6.2.4.9.2. By Application
    • 6.2.4.9.3. By End User

7. Asia Pacific Antimicrobial Resistance Surveillance Market

• 7.1. Market Size & Forecast, 2019-2029
  • 7.1.1. By Value (USD Million)
• 7.2. Market Share & Forecast
  • 7.2.1. By Solution
  • 7.2.2. By Application
  • 7.2.3. By End User
  • 7.2.4. By Country
    • 7.2.4.1. China
    • 7.2.4.1.1. By Solution
    • 7.2.4.1.2. By Application
    • 7.2.4.1.3. By End User
    • 7.2.4.2. India
    • 7.2.4.2.1. By Solution
    • 7.2.4.2.2. By Application
    • 7.2.4.2.3. By End User
    • 7.2.4.3. Japan
    • 7.2.4.3.1. By Solution
    • 7.2.4.3.2. By Application
    • 7.2.4.3.3. By End User
    • 7.2.4.4. South Korea
    • 7.2.4.4.1. By Solution
    • 7.2.4.4.2. By Application
    • 7.2.4.4.3. By End User
    • 7.2.4.5. Australia & New Zealand
    • 7.2.4.5.1. By Solution
    • 7.2.4.5.2. By Application
    • 7.2.4.5.3. By End User
    • 7.2.4.6. Indonesia
    • 7.2.4.6.1. By Solution
    • 7.2.4.6.2. By Application
    • 7.2.4.6.3. By End User
    • 7.2.4.7. Malaysia
    • 7.2.4.7.1. By Solution
    • 7.2.4.7.2. By Application
    • 7.2.4.7.3. By End User
    • 7.2.4.8. Singapore
    • 7.2.4.8.1. By Solution
    • 7.2.4.8.2. By Application
    • 7.2.4.8.3. By End User
    • 7.2.4.9. Vietnam
    • 7.2.4.9.1. By Solution
    • 7.2.4.9.2. By Application
    • 7.2.4.9.3. By End User
    • 7.2.4.10. Rest of APAC
    • 7.2.4.10.1. By Solution
    • 7.2.4.10.2. By Application
    • 7.2.4.10.3. By End User

8. Latin America Antimicrobial Resistance Surveillance Market

• 8.1. Market Size & Forecast, 2019-2029
  • 8.1.1. By Value (USD Million)
• 8.2. Market Share & Forecast
  • 8.2.1. By Solution
  • 8.2.2. By Application
  • 8.2.3. By End User
  • 8.2.4. By Country
    • 8.2.4.1. Brazil
    • 8.2.4.1.1. By Solution
    • 8.2.4.1.2. By Application
    • 8.2.4.1.3. By End User
    • 8.2.4.2. Mexico
    • 8.2.4.2.1. By Solution
    • 8.2.4.2.2. By Application
    • 8.2.4.2.3. By End User
    • 8.2.4.3. Argentina
    • 8.2.4.3.1. By Solution
    • 8.2.4.3.2. By Application
    • 8.2.4.3.3. By End User
    • 8.2.4.4. Peru
    • 8.2.4.4.1. By Solution
    • 8.2.4.4.2. By Application
    • 8.2.4.4.3. By End User
    • 8.2.4.5. Rest of LATAM
    • 8.2.4.5.1. By Solution
    • 8.2.4.5.2. By Application
    • 8.2.4.5.3. By End User

9. Middle East & Africa Antimicrobial Resistance Surveillance Market

• 9.1. Market Size & Forecast, 2019-2029
  • 9.1.1. By Value (USD Million)
• 9.2. Market Share & Forecast
  • 9.2.1. By Solution
  • 9.2.2. By Application
  • 9.2.3. By End User
  • 9.2.4. By Country
    • 9.2.4.1. Saudi Arabia
    • 9.2.4.1.1. By Solution
    • 9.2.4.1.2. By Application
    • 9.2.4.1.3. By End User
    • 9.2.4.2. UAE
    • 9.2.4.2.1. By Solution
    • 9.2.4.2.2. By Application
    • 9.2.4.2.3. By End User
    • 9.2.4.3. Qatar
    • 9.2.4.3.1. By Solution
    • 9.2.4.3.2. By Application
    • 9.2.4.3.3. By End User
    • 9.2.4.4. Kuwait
    • 9.2.4.4.1. By Solution
    • 9.2.4.4.2. By Application
    • 9.2.4.4.3. By End User
    • 9.2.4.5. South Africa
    • 9.2.4.5.1. By Solution
    • 9.2.4.5.2. By Application
    • 9.2.4.5.3. By End User
    • 9.2.4.6. Nigeria
    • 9.2.4.6.1. By Solution
    • 9.2.4.6.2. By Application
    • 9.2.4.6.3. By End User
    • 9.2.4.7. Algeria
    • 9.2.4.7.1. By Solution
    • 9.2.4.7.2. By Application
    • 9.2.4.7.3. By End User
    • 9.2.4.8. Rest of MEA
    • 9.2.4.8.1. By Solution
    • 9.2.4.8.2. By Application
    • 9.2.4.8.3. By End User

10. Competitive Landscape

• 10.1. List of Key Players and Their Offerings
• 10.2. Global Antimicrobial Resistance Surveillance Market Share Analysis, 2022
• 10.3. Competitive Benchmarking, By Operating Parameters
• 10.4. Key Strategic Developments (Mergers, Acquisitions, Partnerships, etc.)

11. Impact of Covid-19 on Global Antimicrobial Resistance Surveillance Market

12. Company Profile (Company Overview, Financial Matrix, Competitive Landscape, Key Personnel, Key Competitors, Contact Address, Strategic Outlook, SWOT Analysis)

• 12.1. Becton, Dickinson and Company
• 12.2. Biomerieux
• 12.3. Thermo Fisher Scientific
• 12.4. Danaher
• 12.5. Luminex Corporation
• 12.6. Bruker
• 12.7. Bio-Rad
• 12.8. Qiagen
• 12.9. Abbott Laboratories
• 12.10. Roche Diagnostics
• 12.11. OpGen, Inc.
• 12.12. Wolters Kluwer N.V.
• 12.13. Lumed
• 12.14. BioSpace
• 12.15. Cepheid
• 12.16. Other Prominent Players

13. Key Strategic Recommendations

14. Research Methodology

• 14.1. Qualitative Research
  • 14.1.1. Primary & Secondary Research
• 14.2. Quantitative Research
• 14.3. Market Breakdown & Data Triangulation
  • 14.3.1. Secondary Research
  • 14.3.2. Primary Research
• 14.4. Breakdown of Primary Research Respondents, By Region
• 14.5. Assumptions & Limitations